首頁 > 市場調查報告書 > 醫療設備

體外診斷

醫療分析檢測服務市場規模、佔有率和成長分析（按類型、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899194

醫療分析檢測服務市場規模、佔有率和成長分析（按類型、最終用戶和地區分類）－2026-2033年產業預測

Healthcare Analytical Testing Services Market Size, Share, and Growth Analysis, By Type (Medical Device Analytical Testing Services, Pharmaceutical Analytical Testing Services), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 168 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，醫療分析測試服務市場規模將達到 82.2 億美元，到 2025 年將達到 91.4 億美元，到 2033 年將達到 213.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 11.2%。

醫療分析檢測服務市場的成長主要受臨床試驗數量增加、生物相似藥發展以及製藥公司外包業務成長的推動。新冠疫情加速了市場擴張，推動了對分析檢測服務的需求，以支持治療方法和疫苗的快速研發。儘管疫情初期造成的衝擊影響了市場成長，但隨後疫苗接種活動的激增和醫療設備創新已使該行業重煥生機。此外，競爭壓力和快速進入市場的需求也促使企業將檢測服務外包。生物相似藥和組合產品的興起，以及新參與企業市場的企業日益嚴格的監管合規要求，進一步凸顯了對特定分析檢測解決方案的迫切需求。

醫療分析檢測服務市場促進因素

對醫療檢測服務需求的不斷成長正顯著推動醫療分析檢測服務市場的發展。這一成長主要源於人口老化和慢性病盛行率的顯著上升，從而帶動了對診斷檢測及相關分析服務的需求。個人化醫療的趨勢也發揮關鍵作用，而個人化醫療高度依賴先進的檢測和分析能力。此外，醫療專業人員和生物製藥公司對分析檢測投入的不斷增加也推動了市場的發展。隨著對準確可靠診斷結果的需求日益成長，醫療檢測服務的擴張預計將持續下去。

醫療分析測試服務市場的限制因素

醫療分析檢測服務市場面臨許多挑戰，主要原因在於其高成本和固有的複雜性。提供這些分析檢測服務需要先進的軟體、專用設備和訓練有素的人員，這些因素都推高了價格。此外，檢測和分析本身的複雜性也可能導致誤差和不一致，從而阻礙市場發展。這些障礙對中小企業的影響尤其顯著，使它們難以投入資源進行分析檢測服務。因此，相關的成本和複雜性可能會抑制整體市場成長，因為企業在權衡利弊時會做出艱難的抉擇。

醫療分析檢測服務市場的發展趨勢

醫療保健分析檢測服務市場正呈現出明顯的趨勢，即分析檢測服務外包，尤其是在生物技術和製藥公司中。這項轉變的主要驅動力是降低營運成本、利用先進技術以及專注於核心競爭力。透過將分析檢測外包給專業服務供應商，企業可以提高生產效率並縮短交付時間，從而依靠擁有必要專業知識和資源的供應商。隨著對分析檢測服務需求的持續成長，外包將成為越來越受歡迎的策略，使企業能夠最佳化營運並在醫療保健領域保持競爭力。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Eurofins Scientific（Luxembourg）
Laboratory Corporation of America Holdings（US）
SGS SA（Switzerland）
Charles River Laboratories（US）
WuXi AppTec Co. Ltd.（China）
Element Materials Technology（UK）
Thermo Fisher Scientific, Inc.（US）
Pace Analytical Services LLC（US）
Intertek Group plc（UK）
IQVIA Inc.（US）
Merck KGaA（Germany）
Source BioScience（UK）
Almac Group（UK）
ICON Plc（Ireland）
Frontage Laboratories, Inc.（US）
STERIS Plc（US）
Sartorius AG（Germany）
ALS Life Science（US）
Syneos Health, INC（US）
Medpace Holdings, Inc.（US）

簡介目錄

Product Code: SQMIG35D2273

Healthcare Analytical Testing Services Market size was valued at USD 8.22 Billion in 2024 and is poised to grow from USD 9.14 Billion in 2025 to USD 21.36 Billion by 2033, growing at a CAGR of 11.2% during the forecast period (2026-2033).

The growth of the Healthcare Analytical Testing Services market is primarily driven by the rising number of clinical trials, an emphasis on biosimilars, and increased outsourcing by pharmaceutical companies. The COVID-19 pandemic has acted as a catalyst for market expansion, spurring demand for analytical testing services in response to the rapid development of treatments and vaccines. While initial disruptions from the pandemic impacted growth, the subsequent surge in vaccination efforts and innovation in medical equipment revitalized the sector. Additionally, competitive pressures and the demand for expedited market entry have prompted companies to outsource testing services. The rise of biosimilars, combination products, and regulatory compliance requirements by firms entering new markets further underscores the critical need for specific analytical testing solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Healthcare Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Healthcare Analytical Testing Services Market Segments Analysis

Global Healthcare Analytical Testing Services Market is segmented by Type, End User, and Region. Based on Type, the market is segmented into Medical Device Analytical Testing Services (Extractable and Leachable, Material Characterization, Physical Testing, Bioburden Testing, Sterility Testing, Others), Pharmaceutical Analytical Testing Services (Bioanalytical Testing, Method Development & Validation, Stability Testing, Other Testing Services). Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Hospitals & Clinics, Forensic Labs, Cosmetic & Nutraceutical Companies. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Healthcare Analytical Testing Services Market

The rising demand for medical testing services significantly propels the growth of the Healthcare Analytical Testing Services market. This surge is largely attributed to an aging population and a notable increase in chronic health conditions, which in turn elevates the need for diagnostic testing and related analytical services. The trend towards personalized medicine also plays a critical role, as it relies heavily on sophisticated testing and analytical capabilities. Furthermore, increased investments from healthcare professionals and biopharmaceutical companies in analytical testing are driving momentum within the market. As the need for accurate and reliable diagnostic results becomes ever more vital, the expansion of healthcare testing services is expected to persist.

Restraints in the Healthcare Analytical Testing Services Market

The Healthcare Analytical Testing Services market faces significant challenges primarily due to high costs and the inherent complexity of services. The provision of these analytical testing services necessitates sophisticated software, specialized equipment, and highly trained personnel, which contribute to elevated pricing. Additionally, the intricate nature of both testing and analysis can result in errors and inconsistencies, potentially hindering market development. These barriers particularly affect small and medium-sized enterprises, making it difficult for them to commit resources to analytical testing services. Consequently, the associated costs and complexities may restrain overall market growth as businesses evaluate the advantages relative to the drawbacks.

Market Trends of the Healthcare Analytical Testing Services Market

The healthcare analytical testing services market is experiencing a significant trend towards the outsourcing of analytical testing services, particularly among biotechnology and pharmaceutical companies. This shift is largely driven by the desire to reduce operational costs, leverage advanced technologies, and concentrate on core business functions. By outsourcing analytical testing to specialized service providers, organizations are enhancing their productivity and achieving quicker turnaround times, as these vendors offer the necessary expertise and resources. As the demand for analytical testing services continues to expand, outsourcing is set to become an increasingly popular strategy, enabling companies to optimize their operations and maintain competitiveness in the healthcare landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Case Study Analysis
Regulatory Landscape
Startup Analysis
Technology Analysis
Innovation Matrix
Market Attractiveness Index, 2025

Healthcare Analytical Testing Services Market, By Type

Market Overview
Medical Device Analytical Testing Services
- Extractable and Leachable
- Material Characterization
- Physical Testing
- Bioburden Testing
- Sterility Testing
- Others
Pharmaceutical Analytical Testing Services
- Bioanalytical Testing
- Method Development & Validation
- Stability Testing
- Other Testing Services

Healthcare Analytical Testing Services Market, By End User

Market Overview
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Hospitals & Clinics
Forensic Labs
Cosmetic & Nutraceutical Companies

Healthcare Analytical Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Element Materials Technology (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pace Analytical Services LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Source BioScience (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERIS Plc (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALS Life Science (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, INC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments